Revised legislation on GM crops in Europe
The prospects for further commercial releases of GM potatoes in North
America, and of any in Europe, clearly await significant consumer acceptance
before consistent, large volume end-user markets emerge. The factors which
will determine acceptance or otherwise are complex and beyond the scope of
this section. However, on 14 February 2001, the European Parliament finally
adopted a joint text concerning the deliberate release into the environment of
genetically modified organisms. The text, which revises the European Directive
90/220/EEC (which itself lays down regulations for commercial releases of
GM crops into the environment), seeks to increase the transparency and
efficiency of the decision-making process on GM crops and products in the
European Union. This in itself may improve public confidence. The revised
directive aims to promote a harmonisation of risk assessment, and to introduce
clear labelling requirements for all GMOs placed on the market. There are
proposals to introduce mandatory monitoring for GM products and mandate a
time limitation (renewable) of ten years, maximum, for first-time consent.
There are plans to introduce compulsory monitoring of GM crops after they
have been placed on the market, to provide for a common methodology to
assess the risks associated with their release, and to include a mechanism to
allow modification, suspension or termination of the release when new
information on risks becomes available.
Other important components of the evolving legislation include: a gradual
elimination of antibiotic resistance markers in commercial GMOs by the end of
2004, and by 2008 for releases into the environment for experimental purposes;
a plan to bring forward a legislative proposal on environmental liability before
the end of 2001, also covering damage resulting from GMOs; public registers of
GMOs released into the environment for experimental purposes; introduction of
general rules on traceability and labeling of GMOs and products derived from
them; mandatory monitoring after GMOs are placed on the market; mandatory
consultation of relevant European Scientific Committee(s); mandatory consultation
of the public concerning both experimental and commercial releases;
the application of the precautionary principle when implementing the Directive;
the opportunity for consulting Ethics Committee(s) on issues of general nature.
An excellent review of international comparisons of regulatory frameworks for
food products of biotechnology has been published by MacKenzie (2000).